The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective observational study of monitoring gene alterations in plasma cell-free DNA using droplet digital PCR system during anti-EGFR antibody treatment in patients with RAS wild-type advanced colorectal cancer.
 
Naoki Takahashi
Honoraria - Bristol-Myers Squibb Japan; Ono Pharmaceutical; Taiho Pharmaceutical
 
Keishi Nakamura
No Relationships to Disclose
 
Yosuke Kito
Honoraria - Daiichi Sakyo; Merck; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Eiji Kubota
No Relationships to Disclose
 
Masako Asayama
Honoraria - Bayer; Merck; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Isofol Medical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Yosuke Kumekawa
Honoraria - Bayer; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Hiroki Hara
Honoraria - Asahi Kasei; Asahi Kasei; Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Merck Serono; MSD; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb Japan; Daiichi Sankyo/UCB Japan; dainippon sumitomo; MSD; Ono Pharmaceutical
Research Funding - ALX Oncology (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Janssen Oncology (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Tomohiro Matsushima
No Relationships to Disclose
 
Kunihiro Tsuji
No Relationships to Disclose
 
Hiromi Kataoka
No Relationships to Disclose
 
Akihiro Tsuyada
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Patents, Royalties, Other Intellectual Property - Riken Genesis Co., Ltd.
 
Yasushi Sasaki
No Relationships to Disclose
 
Masashi Idogawa
No Relationships to Disclose
 
Takashi Tokino
No Relationships to Disclose
 
Takeshi Sawada
No Relationships to Disclose